{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T16:41:03Z","timestamp":1762015263033,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1167,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"FCT - Agency of the Portuguese Governement for support of scientific and tecnhological research"},{"name":"FCT - Agency of the Portuguese Governement for support of scientific and tecnhological research"},{"name":"Ventana Medical Systems partially funded this study through a project grant"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41379-019-0294-9","type":"journal-article","created":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T06:02:12Z","timestamp":1561269732000},"page":"1574-1586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-1391","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Lobo","sequence":"first","affiliation":[]},{"given":"Sara","family":"Petronilho","sequence":"additional","affiliation":[]},{"given":"Amy Hanlon","family":"Newell","sequence":"additional","affiliation":[]},{"given":"Julia","family":"Coach","sequence":"additional","affiliation":[]},{"given":"Greg","family":"Harlow","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9ia","family":"Cruz","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Lopes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3098-0711","authenticated-orcid":false,"given":"Lu\u00eds","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Isaac","family":"Bai","sequence":"additional","affiliation":[]},{"given":"Espen","family":"Walker","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-4666","authenticated-orcid":false,"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1038\/s41379-019-0294-9_bib1","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/annonc\/mdr461","article-title":"Outcome of special types of luminal breast cancer","volume":"23","author":"Colleoni","year":"2012","journal-title":"Ann Oncol"},{"issue":"Suppl 2","key":"10.1038\/s41379-019-0294-9_bib2","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24","author":"Prat","year":"2015","journal-title":"Breast"},{"key":"10.1038\/s41379-019-0294-9_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.semcancer.2017.08.010","article-title":"Prognostic and predictive biomarkers in breast cancer: Past, present and future","volume":"52","author":"Nicolini","year":"2018","journal-title":"Seminars in Cancer Biology"},{"key":"10.1038\/s41379-019-0294-9_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3065","article-title":"The role and function of cadherins in the mammary gland","volume":"14","author":"Andrews","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1038\/s41379-019-0294-9_bib5","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1113\/JP275328","article-title":"Cadherins: cellular adhesive molecules serving as signalling mediators","volume":"596","author":"Yulis","year":"2018","journal-title":"J Physiol"},{"key":"10.1038\/s41379-019-0294-9_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00428-018-2406-1","article-title":"Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features","volume":"473","author":"Ferreira","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-019-0294-9_bib7","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1091\/mbc.E16-01-0058","article-title":"Roles for E-cadherin cell surface regulation in cancer","volume":"27","author":"Petrova","year":"2016","journal-title":"Mol Biol Cell"},{"key":"10.1038\/s41379-019-0294-9_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10120-011-0004-x","article-title":"Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer","volume":"14","author":"Uchikado","year":"2011","journal-title":"Gastric Cancer"},{"key":"10.1038\/s41379-019-0294-9_bib9","first-page":"1125","article-title":"The prognostic value of cadherin switch in bladder cancer","volume":"23","author":"Jager","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1038\/s41379-019-0294-9_bib10","first-page":"1659","article-title":"Significance and prognosis of epithelial-cadherin expression in invasive breast carcinoma","volume":"16","author":"Yang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1038\/s41379-019-0294-9_bib11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/B978-0-12-394311-8.00014-5","article-title":"Cadherins and epithelial-to-mesenchymal transition","volume":"116","author":"Gheldof","year":"2013","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1038\/s41379-019-0294-9_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4297\/najms.2011.3227","article-title":"E-Cadherin as a diagnostic biomarker in breast cancer","volume":"3","author":"Singhai","year":"2011","journal-title":"N Am J Med Sci"},{"key":"10.1038\/s41379-019-0294-9_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-015-0448-4","article-title":"P-cadherin and the journey to cancer metastasis","volume":"14","author":"Vieira","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1038\/s41379-019-0294-9_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/path.4143","article-title":"P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model","volume":"229","author":"Ribeiro","year":"2013","journal-title":"J Pathol"},{"key":"10.1038\/s41379-019-0294-9_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/modpathol.2010.189","article-title":"P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer","volume":"24","author":"Turashvili","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-019-0294-9_bib16","doi-asserted-by":"crossref","first-page":"12691","DOI":"10.1074\/jbc.M708887200","article-title":"A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus","volume":"283","author":"Ferber","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1038\/s41379-019-0294-9_bib17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/jcmm.12340","article-title":"From cell membrane to the nucleus: an emerging role of E-cadherin in gene transcriptional regulation","volume":"18","author":"Du","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1038\/s41379-019-0294-9_bib18","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1210\/jc.2008-2075","article-title":"Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas","volume":"94","author":"Elston","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-019-0294-9_bib19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.5858\/2000-124-1147-NLOECE","article-title":"Nuclear localization of E-cadherin expression in Merkel cell carcinoma","volume":"124","author":"Han","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-019-0294-9_bib20","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2353\/ajpath.2010.100079","article-title":"Site-dependent E-cadherin cleavage and nuclear translocation in a metastatic colorectal cancer model","volume":"177","author":"Cespedes","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-019-0294-9_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/dc.10030","article-title":"Immunocytochemical expression of E-cadherin on fine-needle aspirates from breast carcinomas correlate with the cell dissociation pattern seen on smears","volume":"25","author":"Sauer","year":"2001","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/s41379-019-0294-9_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1309\/FDHX-L92R-BATQ-2GE0","article-title":"Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications","volume":"115","author":"Acs","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-019-0294-9_bib23","first-page":"840","article-title":"E-cadherin expression: a diagnostic utility for differentiating breast carcinomas with ductal and lobular morphologies","volume":"7","author":"Pai","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1038\/s41379-019-0294-9_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAP.0b013e31817bf566","article-title":"Nuclear E-cadherin immunoexpression: from biology to potential applications in diagnostic pathology","volume":"15","author":"Chetty","year":"2008","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/s41379-019-0294-9_bib25","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1158\/0008-5472.CAN-12-2368","article-title":"Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer","volume":"72","author":"Qian","year":"2012","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-019-0294-9_bib26","series-title":"AJCC Cancer Staging Manual","first-page":"589","article-title":"Breast","author":"Hortobagyi","year":"2016"},{"key":"10.1038\/s41379-019-0294-9_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-16366-6_1","article-title":"Breast cancer survivorship: where are we today?","volume":"862","author":"Ganz","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1038\/s41379-019-0294-9_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12013-014-0459-6","article-title":"Breast cancer: epidemiology and etiology","volume":"72","author":"Tao","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"10.1038\/s41379-019-0294-9_bib29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Dabbs","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0294-9_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7819-3-73","article-title":"Aberrant E-cadherin staining patterns in invasive mammary carcinoma","volume":"3","author":"Harigopal","year":"2005","journal-title":"World J Surg Oncol"},{"key":"10.1038\/s41379-019-0294-9_bib31","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/PAS.0b013e3181f01916","article-title":"Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast","volume":"34","author":"Rakha","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0294-9_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.pas.0000213413.33558.85","article-title":"Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression","volume":"31","author":"Izumi","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0294-9_bib33","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.5858\/2006-130-1320-DEPOEA","article-title":"Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma","volume":"130","author":"Moon","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-019-0294-9_bib34","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/labinvest.3700684","article-title":"Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma","volume":"87","author":"Gervais","year":"2007","journal-title":"Lab Invest"},{"key":"10.1038\/s41379-019-0294-9_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/modpathol.3800990","article-title":"Frequent accumulation of nuclear E-cadherin and alterations in the Wnt signaling pathway in esophageal squamous cell carcinomas","volume":"21","author":"Salahshor","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-019-0294-9_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/PAS.0b013e31813547f8","article-title":"Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors","volume":"32","author":"Chetty","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-019-0294-9_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2559.2007.02949.x","article-title":"Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E\u2010cadherin molecule","volume":"52","author":"Chetty","year":"2008","journal-title":"Histopathology"},{"key":"10.1038\/s41379-019-0294-9_bib38","first-page":"296","article-title":"Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas","volume":"8","author":"Serra","year":"2007","journal-title":"JOP"},{"key":"10.1038\/s41379-019-0294-9_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.17","article-title":"An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt\/beta-catenin-elicited promotion of the cancer stem cell phenotype","volume":"4","author":"Su","year":"2015","journal-title":"Oncogenesis"},{"key":"10.1038\/s41379-019-0294-9_bib40","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1245\/s10434-012-2709-4","article-title":"Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder","volume":"20","author":"Keck","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/s41379-019-0294-9_bib41","first-page":"1919","article-title":"E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain","volume":"13","author":"Berx","year":"1996","journal-title":"Oncogene"},{"key":"10.1038\/s41379-019-0294-9_bib42","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1038\/sj.onc.1204505","article-title":"Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene","volume":"20","author":"Cheng","year":"2001","journal-title":"Oncogene"},{"key":"10.1038\/s41379-019-0294-9_bib43","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1073\/pnas.92.16.7416","article-title":"Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas","volume":"92","author":"Yoshiura","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41379-019-0294-9_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ijc.11197","article-title":"Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability","volume":"106","author":"Sarrio","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-019-0294-9_bib45","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-05-0059","article-title":"P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation","volume":"11","author":"Paredes","year":"2005","journal-title":"Clin Cancer Res"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0294-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222009814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222009814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-019-0294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:42:28Z","timestamp":1760229748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222009814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0893395222009814"],"URL":"https:\/\/doi.org\/10.1038\/s41379-019-0294-9","relation":{},"ISSN":["0893-3952"],"issn-type":[{"type":"print","value":"0893-3952"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-019-0294-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}